Injectable codeine is accessible for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can result in nonimmune mast-mobile degranulation and ensuing anaphylactoid response. Codeine suppositories can also be marketed in some international locations. In Ireland, new laws arrived into impact on 1 August 2010[90] about codeine, as https://www.codeingil.com/